Related Experiment Videos
Metabolism and toxicity of 2-methylpropene (isobutene)--a review
Abstract:
2-Methylpropene (MP) or isobutene is a gaseous chemical used on a large scale in the synthetic rubber industry. The present review covers the rather scarce literature on MP with respect to its metabolic fate and toxicity in laboratory animals and humans. It has been shown both in vivo and in vitro that MP is metabolized to the primary metabolite 2-methyl-1,2-epoxypropane (MEP) by rodent and human liver tissue. The formation of this reactive epoxide intermediate is catalyzed by CYP2E1, while epoxide hydrolase and glutathione S-transferase appear to be involved in its inactivation. In rats, the capacity to absorb and metabolize MP is saturable. MP is oxidized to compounds that are mainly excreted in urine. Data indicate that rodents can tolerate low levels of MP without apparent toxicity. The primary metabolite MEP, however, is able to produce genetic damage in both prokaryotic and eukaryotic cells in vitro. MP is thus not toxic per se but elicits metabolic activation to become potentially harmful. Consequently, the balance between formation and detoxification of MEP plays a key role in determining the potential toxicity of the parent compound. Obviously, further research, including repeated exposure toxicity studies, is required before an estimation of the risk for man can be made.
Insights
2-Methylpropene (MP) is metabolized to a reactive epoxide (MEP) in the liver. While low MP levels are tolerated, the metabolite MEP can cause genetic damage, highlighting the importance of metabolic balance for toxicity.
Area of Science:
- Toxicology
- Metabolic Biochemistry
- Environmental Health
Background:
- 2-Methylpropene (isobutene) is a key industrial chemical, primarily used in synthetic rubber production.
- Limited literature exists on the metabolic fate and toxicity of 2-Methylpropene (MP).
- Understanding MP's metabolism is crucial for assessing its potential health risks.
Purpose of the Study:
- To review the available literature on the metabolic fate and toxicity of 2-Methylpropene (MP).
- To identify the primary metabolites and metabolic pathways involved in MP processing.
- To evaluate the toxicological implications of MP exposure and its metabolites.
Main Methods:
- Literature review of in vivo and in vitro studies on MP metabolism and toxicity.
- Identification of key enzymes involved in MP metabolic activation and detoxification (CYP2E1, epoxide hydrolase, glutathione S-transferase).
- Assessment of MP and its metabolite MEP in rodent and human liver systems.
Main Results:
- 2-Methylpropene (MP) is metabolized to 2-methyl-1,2-epoxypropane (MEP) by rodent and human liver enzymes, notably CYP2E1.
- MEP is a reactive epoxide intermediate capable of causing genetic damage in vitro.
- MP absorption and metabolism in rats are saturable processes, with metabolites primarily excreted in urine.
- Rodents tolerate low MP levels, but the toxicity is linked to the balance between MEP formation and detoxification.
Conclusions:
- 2-Methylpropene (MP) itself is not acutely toxic but requires metabolic activation to a harmful epoxide (MEP).
- The balance between MEP production and its detoxification is critical in determining MP's overall toxicity.
- Further research, including repeated exposure studies, is necessary to fully assess human health risks associated with MP.